prostate
Enable an AI agent to recognise a prostate, record evidence about its anatomy and condition, and identify appropriate assessment or management options without treating uncertain findings as diagnoses.
Bundle → Layer → Finding → Questions Filled
6 bundles · 11 layers · 18 findings · 30 questions
Prostate identity and anatomy Establishes which prostate or prostate-derived tissue is being described and how its internal regions and neighbours are situated.
Organ identity and presence
Connects the anatomical entity to its host and establishes whether an intact or altered prostate is present.
Identified prostate entity
Records the basis for identifying the entity as a prostate, residual prostate tissue or a specimen derived from it.
- Does this record describe an intact prostate, a treated or residual gland, or a prostate-derived specimen? definition
- Which imaging, operative or pathology record establishes its identity and connection to the host organism? provenance
Zones and adjacent structures
Locates prostate tissue and findings relative to internal zones, the urethra, bladder neck and surrounding tissues.
Prostate spatial map
Preserves the anatomical landmarks needed to locate observations and interpret local boundaries.
- Which zone or region, side and apex-to-base level contains each recorded finding? boundary
- How are the urethra, bladder neck, seminal vesicles and outer gland boundary situated, and which boundaries are obscured or altered? boundary
Prostate function and local effects Records evidence about prostatic secretion and the gland's contribution to urinary and ejaculatory function.
Secretory and ejaculatory role
Connects prostate tissue and ductal pathways to their contribution to ejaculate.
Prostatic secretory contribution
Records evidence or uncertainty concerning gland secretion and its delivery, including changes after treatment.
- What evidence addresses prostatic secretion or ductal patency, and is it direct or inferred from broader reproductive observations? provenance
- Which observed ejaculatory changes can reasonably be attributed to the prostate or its treatment, and which remain attributable to neighbouring systems? boundary
Urinary outflow interface
Describes how prostate anatomy may affect the prostatic urethra and bladder outlet.
Prostate-related outflow compromise
Separates anatomical narrowing or protrusion from symptoms and functional evidence of obstruction.
- What anatomical evidence shows urethral compression, bladder-outlet distortion or intravesical prostatic protrusion? measurement
- Which linked urinary assessments support a prostate contribution, and what competing bladder or urethral explanations remain? boundary
Prostate morphology and tissue condition Describes gland enlargement, focal abnormalities and evidence of inflammatory or infectious processes.
Size and growth pattern
Captures whole-gland size, regional enlargement and changes over time.
Measured gland enlargement
Records dimensions and regional growth without treating enlargement as proof of histological hyperplasia or obstruction.
- What are the gland dimensions and estimated volume, measured when and by which method? measurement
- Is enlargement diffuse or regionally concentrated, and is apparent interval growth distinguishable from measurement variation? measurement
Inflammation, infection and focal change
Localises tissue abnormalities and preserves the evidence supporting proposed causes.
Localised nonneoplastic or unresolved abnormality
Records suspected inflammation, infection, abscess, cysts, calculi or other focal changes without assigning an unsupported cause.
- Where is the abnormality, what is its extent, and what examination, imaging or tissue evidence characterises it? measurement
- What evidence supports inflammation or infection within the prostate, and does any organism identification come from a specimen that supports that attribution? provenance
- Does the documented finding warrant prompt clinical assessment, and what observed feature supports that urgency? action
Prostate neoplasia evidence Connects prostate-localised suspicion, sampling and pathological interpretation while retaining uncertainty.
Biomarker and imaging suspicion
Links serum PSA and prostate imaging to the circumstances in which they were obtained.
Contextualised cancer suspicion
Records evidence that raises or reduces concern while preserving alternative explanations and assessment limitations.
- Which PSA results and trends are available, and what medications, inflammation or recent procedures could affect their interpretation? provenance
- Which prostate lesions were reported on imaging, with what location, dimensions and assessment category under the stated reporting system? measurement
Sampling and local extent
Relates sampled tissue to prostate locations and distinguishes sampled findings from whole-gland conclusions.
Pathology-supported prostate involvement
Records pathological diagnosis, reported grade and involvement together with sampling coverage and evidence of local extension.
- Which targeted or systematic samples support the reported diagnosis, grade and extent of involvement? provenance
- Which regions remain unsampled or uncertain, and what evidence supports or excludes extension beyond the gland within the limits of the assessment? boundary
Prostate-directed action and follow-up Connects proposed and completed interventions to their prostate targets, anatomical constraints and subsequent observations.
Assessment and treatment targets
Identifies the prostate-specific question or tissue target that a proposed action would address.
Justified prostate-directed action
Records the rationale and local constraints for clinician-reviewed examination, sampling, surveillance or treatment.
- What unresolved prostate finding or confirmed condition would the proposed assessment or intervention address? action
- Which gland dimensions, lesion locations, prior treatments and relationships to the urethra, sphincter or neurovascular structures constrain the action? boundary
Post-intervention state
Tracks residual anatomy, treatment effects and evidence of persistence or recurrence.
Interpretable prostate follow-up
Compares subsequent observations against a treatment-appropriate baseline and records local complications or unresolved findings.
- What tissue was removed or treated, when, and what prostate tissue is documented to remain? provenance
- How have gland or lesion measurements and associated PSA changed relative to the intervention and its expected assessment timeline? measurement
- Which findings warrant continued surveillance or reassessment for residual disease, recurrence or a local treatment complication? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Kinds and varieties
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these kinds and varieties hold for the sense of prostate this model covers, and on what evidence? provenance
Identifiers and schemes
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these identifiers and schemes hold for the sense of prostate this model covers, and on what evidence? provenance
Standards and regulation
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these standards and regulation hold for the sense of prostate this model covers, and on what evidence? provenance
Real-world use
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these real-world use hold for the sense of prostate this model covers, and on what evidence? provenance
Typical measurements
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these typical measurements hold for the sense of prostate this model covers, and on what evidence? provenance
Failure modes and hazards
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these failure modes and hazards hold for the sense of prostate this model covers, and on what evidence? provenance
Regional variation
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these regional variation hold for the sense of prostate this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of prostate this model covers, and on what evidence? provenance
Classifiers Filled
- Family
- Thing Registry
- Category
- Physical world and living systems
- Entry kind
- thing
- Plane
- PHY
- Domain
- PHY.OBJ
What it is Filled
The prostate is an accessory gland of the male reproductive system in most mammals that contributes secretions to semen, with anatomy and secretion characteristics varying across species. In humans, it is normally an unpaired gland immediately inferior to the urinary bladder and surrounding the prostatic urethra, with branched tubuloalveolar glands and fibromuscular stroma that produce zinc-rich, normally slightly acidic fluid forming a substantial fraction of the ejaculate. Human prostatic zonal architecture is relevant to the distribution of conditions such as benign prostatic hyperplasia, prostatitis and prostatic adenocarcinoma.
In scope
- Identification of the prostate and its anatomical boundaries, including altered or residual anatomy
- Gland size, shape, tissue organisation and spatially localised findings
- Prostatic secretory function and relationships to ejaculation and urinary outflow
- Evidence concerning enlargement, inflammation, infection and neoplasia
- Prostate-directed assessments, interventions and resulting changes
Out of scope
- Whole-person diagnosis, preferences, consent and overall treatment eligibility
- Bladder, urethral, ureteric, testicular and seminal-vesicle models beyond their relationships to the prostate
- Complete models of urinary disorders, sexual function or fertility
- Independent models of prostate cancer, metastatic disease and systemic infection
- Laboratory assays, imaging devices, medicines and surgical procedures as independently managed things
Why it exists Filled
Enable an AI agent to recognise a prostate, record evidence about its anatomy and condition, and identify appropriate assessment or management options without treating uncertain findings as diagnoses.
Distinguishing features Filled
- In typical human anatomy, it lies inferior to the bladder and surrounds the proximal urethra; the bladder is a urine reservoir rather than glandular tissue surrounding that urethral segment.
- In humans, it is a single organ with zonal glandular organisation and an anterior fibromuscular region; the seminal vesicles are paired structures posterior to the bladder.
- In humans, its glandular ducts communicate with the prostatic urethra; the bulbourethral glands lie inferior to the prostate and drain into a different urethral segment.
- A biopsy or resected fragment represents prostate tissue only when specimen provenance and pathological interpretation support that identity; it is not automatically the whole organ.
What robots and AI may and may not do Filled
Must not
- Diagnose prostate disease or interpret a person's test results as if it were their doctor.
- Recommend for or against screening or treatment for a specific person.
- Disclose a person's prostate health records without consent.
- Promote unproven remedies as treatments for prostate conditions.
Only with a human decision
- Any decision on biopsy, surgery or other treatment of the prostate.
May
- Explain the anatomy and function of the prostate in general terms from medical sources.
- Point a person reporting urinary symptoms toward a qualified clinician.
Moral aspects Filled
- Prostate conditions are common and often embarrassing to discuss; dignity and privacy matter.
- Screening decisions involve real trade-offs between early detection and overtreatment.
Who is affected
- Patients with prostate conditions
- Their partners and families
- Transgender women and others who have a prostate
Owners Filled
Steward
Nobody owns the organ in general; each person's own body and their clinician answer for care.
Links to other meta-models Filled
parent
- Q112826975 - registry parent class
- Q12229458 - registry parent class
- Q28846466 - registry parent class
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.prostate
- Wikidata: Q9625 (https://www.wikidata.org/wiki/Q9625)
Direct properties required Filled
- Anatomical presence: Present; partially resected; residual tissue identified; removed by documented procedure; indeterminate
- Host organism and developmental context: Link to organism, species, age or developmental stage, and relevant hormonal context
- Gland dimensions and volume: Dimensions in mm; volume in mL, with acquisition method, estimation method and date
- Anatomical zone and location: Peripheral zone; transition zone; central zone; anterior fibromuscular stroma; unspecified, with side and apex-to-base position
- Relationship to urinary outflow: No demonstrated compromise; suspected contribution; supported contribution; indeterminate
- Focal finding extent: Dimensions in mm and documented location, method and date
- Tissue interpretation: Reported benign, inflammatory, atypical, malignant or nondiagnostic interpretation, with specimen and report links
- Associated serum PSA: Link to serum prostate-specific antigen result in ng/mL, assay, date and relevant clinical context
- Local tissue extension: Confined appearance; suspected extension; confirmed extension; indeterminate, with affected structure and evidence
- Treatment-altered anatomy: Untreated; medically modified; resected; ablated; irradiated; combined; unknown, with intervention dates
Recognition required Filled
- In typical adult human anatomy, the prostate is a walnut-sized gland sitting just below the bladder and surrounding the start of the urethra.
- In human imaging, it appears as a rounded structure in front of the rectum.
Capabilities and actions required Filled
- Locate and delineate the gland and prostate-specific regions using documented anatomical or imaging evidence.
- Measure gland size and compare localised findings across examinations while retaining method differences.
- Associate symptoms, PSA results, imaging and tissue findings to assess possible prostate involvement without asserting unsupported causation.
- Identify whether further prostate-directed examination, imaging or sampling warrants clinical consideration.
- Represent prostate-directed treatment targets and anatomical constraints for review by qualified clinicians.
- Track gland response, residual tissue and local complications after intervention.
Hazards and failure modes required Filled
- Benign enlargement can block urine flow and cause urinary retention.
- Prostate cancer can grow without early symptoms.
- Prostatitis causes pain and infection that can recur.
Standards and interfaces required Filled
- International Classification of Diseases (ICD-11), World Health Organization, which codes prostate diseases.
Context of use required Filled
- The prostate contributes secretions to semen and is encountered in reproductive anatomy and veterinary or human clinical assessment.
- In humans it lies below the urinary bladder around the proximal urethra, making its condition relevant to both urinary and reproductive function.
- Its structure and distribution vary among mammalian species, so anatomical observations require species-specific interpretation.
Sources Filled
- The zonal anatomy of the prostate - McNeal zonal subdivision (peripheral, transition, central, anterior fibromuscular stroma) that pathology, radiology and urology still use.
- Gray's Anatomy: The Anatomical Basis of Clinical Practice - Gross relations (bladder neck, urethra, seminal vesicles, rectum), classical lobes, and glandular/stromal histology.
- WHO Classification of Tumours: Urinary and Male Genital Tumours, 5th edition - Tumour types arising in the gland, ISUP/WHO grade groups, and the organ as an ICD-O topography (C61).
- Terminologia Anatomica - Official anatomical name Prostata and the TA code used in anatomical nomenclature.
- Campbell-Walsh-Wein Urology - Clinical encounter (DRE, PSA, TURP/HoLEP, radical prostatectomy), BPH physiology, and treatment-related harms.
- PI-RADS: Prostate Imaging-Reporting and Data System (v2.1) - How the living gland is zoned and scored on multiparametric MRI in current practice.
- Wikidata item Q9625: prostate - identity and sense of the item
- Wikipedia: Prostate - general description of the item
Open questions
- Does the registry intend this entry to cover human prostates only, or must species-specific anatomy and terminology be represented?
- Which existing Vercy models own prostate cancer, prostatitis, benign prostatic hyperplasia and prostate-derived specimens, and how should this organ model link to them?
- Which authoritative anatomical and clinical sources should establish the model's terminology and evidence requirements?
- Which versions of imaging, pathology and clinical assessment systems should be referenced, and how should version changes affect comparison over time?
- How should identity and longitudinal continuity be represented after partial resection, focal ablation or radical prostatectomy, particularly when only a surgical bed or uncertain residual tissue remains?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q9625/spec.json